0,945  0,002  NOS2 expression inhibitor
0,934  0,002  Monophenol monooxygenase inhibitor
0,921  0,002  AR expression inhibitor
0,911  0,003  CYP2C19 substrate
0,904  0,003  Lipoxygenase inhibitor
0,897  0,004  15-Lipoxygenase inhibitor
0,896  0,004  Aryl hydrocarbon receptor agonist
0,882  0,004  Radioprotector
0,877  0,002  CTGF expression inhibitor
0,865  0,004  CYP1A2 inhibitor
0,862  0,002  Melanin inhibitor
0,860  0,003  Skin whitener
0,856  0,010  Apoptosis agonist
0,849  0,004  Chemoprotective
0,837  0,004  12-Lipoxygenase inhibitor
0,833  0,003  UGT1A9 substrate
0,822  0,002  UGT1A3 substrate
0,830  0,011  Transcription factor NF kappa B inhibitor
0,821  0,004  Antioxidant
0,791  0,006  Chemopreventive
0,777  0,003  UGT1A1 substrate
0,779  0,007  Antihypercholesterolemic
0,763  0,005  Antiosteoporotic
0,762  0,005  Aldehyde oxidase inhibitor
0,771  0,015  Caspase 9 stimulant
0,755  0,005  Bone diseases treatment
0,766  0,020  Antiinflammatory
0,753  0,009  CYP2C9 substrate
0,746  0,005  Caspase 3 stimulant
0,743  0,003  NOS3 expression enhancer
0,744  0,009  Carcinogenic
0,749  0,014  Antineoplastic (breast cancer)
0,731  0,003  Antihypotensive
0,727  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,747  0,026  Alpha-glucosidase inhibitor
0,724  0,004  CYP2C19 inhibitor
0,725  0,006  CYP2D6 substrate
0,723  0,005  Free radical scavenger
0,730  0,015  Antineoplastic (lung cancer)
0,717  0,008  CYP1A2 substrate
0,716  0,007  Cytostatic
0,696  0,004  MAO A inhibitor
0,696  0,004  MAO inhibitor
0,690  0,005  Antineoplastic (glioma)
0,686  0,007  Cardiovascular analeptic
0,671  0,008  Proliferative diseases treatment
0,666  0,005  Antimutagenic
0,653  0,005  UDP-glucuronosyltransferase substrate
0,656  0,008  NOS3 expression inhibitor
0,647  0,004  Breast cancer-resistant protein inhibitor
0,631  0,008  CYP2C9 inhibitor
0,625  0,008  Cardioprotectant
0,627  0,010  Antineoplastic (melanoma)
0,622  0,009  Nitric oxide antagonist
0,616  0,003  Estrogen receptor alpha antagonist
0,625  0,015  Prostate cancer treatment
0,613  0,008  Antineoplastic (brain cancer)
0,622  0,022  TNF expression inhibitor
0,604  0,004  Sulfotransferase substrate
0,611  0,017  Respiratory analeptic
0,599  0,009  UGT1A6 substrate
0,610  0,022  Antineoplastic (colorectal cancer)
0,615  0,027  CYP3A4 substrate
0,607  0,021  Antineoplastic (colon cancer)
0,586  0,005  Carcinogenic, group 3
0,593  0,014  Mutagenic
0,602  0,024  Antileukemic
0,594  0,020  Antibacterial
0,565  0,004  Amylase inhibitor
0,566  0,006  Antihypoxic
0,557  0,004  Lipid peroxidase inhibitor
0,554  0,005  MAO B inhibitor
0,554  0,007  Antihypertriglyceridemic
0,557  0,018  Sensitization
0,540  0,004  Protein-tyrosine phosphatase inhibitor
0,532  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,528  0,006  Genotoxic
0,537  0,019  Histamine release inhibitor
0,527  0,019  Antineoplastic (cervical cancer)
0,510  0,003  Beta glucuronidase inhibitor
0,514  0,011  Antineoplastic (osteosarcoma)
0,511  0,011  Vascular (periferal) disease treatment
0,517  0,025  Antineoplastic (ovarian cancer)
0,508  0,019  Apoptosis antagonist
0,509  0,022  Spasmolytic
0,499  0,014  Antineoplastic (glioblastoma multiforme)
0,497  0,015  Hypoglycemic
0,484  0,002  Papain-like protease (SARS coronavirus) inhibitor
0,502  0,028  Streptokinase A inhibitor
0,481  0,017  Antiparasitic
0,470  0,007  Bone formation stimulant
0,459  0,004  Heat shock protein 90 antagonist
0,471  0,017  Amyloid beta aggregation inhibitor
0,458  0,009  Hepatoprotectant
0,472  0,024  Antineoplastic (pancreatic cancer)
0,498  0,051  Antidiabetic
0,498  0,051  Cyclophilin D inhibitor
0,448  0,004  Estrogen receptor beta antagonist
0,437  0,005  Alkaline phosphatase inhibitor
0,455  0,022  Antiprotozoal (Leishmania)
0,453  0,022  ICAM1 expression inhibitor
0,445  0,017  Vasodilator
0,438  0,013  Antihelmintic
0,426  0,002  Fatty acid synthase inhibitor
0,446  0,025  Antineoplastic (non-small cell lung cancer)
0,451  0,031  Hepatic disorders treatment
0,445  0,025  Antineoplastic (multiple myeloma)
0,421  0,005  Aldehyde dehydrogenase inhibitor
0,414  0,004  Histidine decarboxylase inhibitor
0,428  0,018  Antineoplastic (renal cancer)
0,426  0,017  Myocardial infarction treatment
0,430  0,022  Antiprotozoal (Trypanosoma)
0,413  0,005  5-Lipoxygenase inhibitor
0,411  0,004  Estrogen antagonist
0,433  0,031  Analeptic
0,397  0,005  Xanthine oxidase inhibitor
0,441  0,050  Immunosuppressant
0,417  0,026  Antiamyloidogenic
0,405  0,015  UGT1A4 substrate
0,426  0,038  Antifungal
0,397  0,010  Topoisomerase II inhibitor
0,382  0,009  UGT2B15 substrate
0,370  0,005  Antihemorrhagic
0,382  0,020  RNA-directed DNA polymerase inhibitor
0,415  0,055  GABA C receptor rho-3 antagonist
0,364  0,007  Heat shock protein 90 alpha antagonist
0,378  0,023  Antiulcerative
0,393  0,040  Lipoprotein disorders treatment
0,357  0,004  Estrogen agonist
0,367  0,019  P-glycoprotein inhibitor
0,377  0,031  Superoxide dismutase inhibitor
0,351  0,007  NADPH oxidase inhibitor
0,348  0,005  Antibacterial (Helicobacter pylori)
0,344  0,004  Gastritis treatment
0,342  0,002  SULT1E1 substrate
0,374  0,035  Huntington's disease treatment
0,398  0,060  Ulceration
0,355  0,018  Platelet adhesion inhibitor
0,366  0,030  Antineoplastic (liver cancer)
0,374  0,039  Cytotoxic
0,364  0,029  Pyruvate kinase inhibitor
0,344  0,016  VCAM1 expression inhibitor
0,368  0,043  CYP3A4 inhibitor
0,369  0,047  Vasodilator, coronary
0,320  0,005  Aromatase inhibitor
0,338  0,023  Dual specificity phosphatase inhibitor
0,356  0,042  UGT2B4 substrate
0,327  0,012  Neurotrophic factor enhancer
0,323  0,010  Antineoplastic (bone cancer)
0,313  0,004  CF transmembrane conductance regulator agonist
0,325  0,019  Mcl-1 antagonist
0,308  0,003  DOPA decarboxylase inhibitor
0,310  0,004  Postmenopausal disorders treatment
0,335  0,030  Antineoplastic enhancer
0,318  0,014  CYP2B6 inhibitor
0,307  0,006  Dementia treatment
0,396  0,098  Alzheimer's disease treatment
0,302  0,007  Vascular dementia treatment
0,300  0,007  Topoisomerase II alpha inhibitor
0,295  0,008  Neurotrophic factor
0,307  0,021  Pneumotoxic
0,331  0,046  Antipyretic
0,324  0,040  Angiogenesis stimulant
0,342  0,059  Antimycobacterial
0,288  0,012  Chelator
0,297  0,022  Antineoplastic (squamous cell carcinoma)
0,309  0,036  Peroxidase inhibitor
0,277  0,004  Lipase inhibitor
0,357  0,088  Antiprotozoal
0,319  0,050  DNA damaging
0,278  0,011  Carcinogenic, group 2B
0,363  0,097  Antiparkinsonian
0,291  0,028  UGT2B7 substrate
0,329  0,070  Immunostimulant
0,263  0,009  VEGF expression inhibitor
0,262  0,014  Cystathionine beta-synthase inhibitor
0,265  0,018  Acetylcholinesterase inhibitor
0,261  0,014  SULT1A3 substrate
0,252  0,006  ABCA1 expression enhancer
0,259  0,016  Antifungal enhancer
0,260  0,019  Cyclooxygenase 1 inhibitor
0,243  0,005  Interleukin 5 antagonist
0,244  0,007  Photosensitizer
0,298  0,064  Antidiabetic (type 2)
0,253  0,019  Antidiarrheal
0,329  0,096  GST A substrate
0,257  0,029  Antiviral (West Nile virus)
0,235  0,012  SULT1A1 substrate
0,263  0,041  DNA methyltransferase I inhibitor
0,225  0,004  Neuraminidase inhibitor
0,239  0,019  Cholesterol synthesis inhibitor
0,252  0,033  Insulin sensitizer
0,285  0,066  Teratogen
0,239  0,020  Antiprotozoal (Coccidial)
0,253  0,037  Male reproductive disfunction treatment
0,300  0,092  Angiogenesis inhibitor
0,254  0,046  Abortion inducer
0,249  0,043  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,269  0,066  Tumour necrosis factor alpha release inhibitor
0,263  0,063  Antiglaucomic
0,261  0,062  Hypolipemic
0,202  0,004  Estrogen receptor alpha agonist
0,298  0,102  Prostaglandin dehydrogenase inhibitor
0,230  0,036  Antineoplastic (carcinoma)
0,199  0,004  Phosphodiesterase VI inhibitor
0,263  0,069  Embryotoxic
0,199  0,010  Antineoplastic (uterine cancer)
0,259  0,070  Antidiabetic symptomatic
0,203  0,015  Coagulant
0,190  0,005  Neuraminidase (influenza) inhibitor
0,218  0,034  Phospholipase A2 inhibitor
0,221  0,039  Antiviral (Herpes)
0,217  0,035  Antiseptic
0,204  0,025  Topoisomerase I inhibitor
0,211  0,033  Skin irritative effect
0,241  0,065  Interleukin antagonist
0,198  0,022  Farnesoid X receptor antagonist
0,186  0,011  NAD(P)H dehydrogenase (quinone) inhibitor
0,220  0,046  Amyloid beta precursor protein antagonist
0,195  0,022  Antineoplastic antibiotic
0,191  0,018  MAP kinase kinase 4 inhibitor
0,208  0,036  UGT2B9 substrate
0,213  0,044  Antineoplastic (gastric cancer)
0,199  0,033  Arachidonic acid antagonist
0,208  0,043  Cholinergic
0,170  0,006  Estrogen receptor beta agonist
0,224  0,060  Wound healing agent
0,245  0,083  Antineoplastic (bladder cancer)
0,223  0,064  DNA methylase inhibitor
0,176  0,017  TRPA1 agonist
0,161  0,005  Ca(v)3.1 blocker
0,160  0,006  Xanthine dehydrogenase inhibitor
0,217  0,064  Antiviral (Influenza)
0,228  0,075  Antineoplastic (lymphoma)
0,192  0,039  Tubulin antagonist
0,165  0,017  Alcohol dehydrogenase inhibitor
0,217  0,070  Antialcoholic
0,156  0,011  Peroxisome proliferator-activated receptor gamma agonist
0,149  0,006  CDC25B inhibitor
0,194  0,053  Succinate dehydrogenase inhibitor
0,187  0,050  Antiviral (Influenza A)
0,237  0,099  Antituberculosic
0,165  0,030  Expectorant
0,169  0,034  Gout treatment
0,184  0,051  UGT2B10 substrate
0,145  0,013  Ornithine decarboxylase inhibitor
0,164  0,031  Interleukin 1b antagonist
0,297  0,169  5 Hydroxytryptamine release inhibitor
0,139  0,012  Aldose reductase inhibitor
0,178  0,051  Cyclooxygenase inhibitor
0,189  0,065  LDLR expression enhancer
0,141  0,020  Thioredoxin inhibitor
0,136  0,015  CDC25A inhibitor
0,247  0,127  Cholesterol antagonist
0,141  0,021  Phosphodiesterase 4D inhibitor
0,195  0,076  Non-steroidal antiinflammatory agent
0,148  0,030  AMP-activated protein kinase stimulant
0,159  0,042  Antiprotozoal (Trichomonas)
0,159  0,042  Interleukin 4 antagonist
0,127  0,011  SULT1A2 substrate
0,143  0,027  Creatine kinase inhibitor
0,149  0,035  Butyrylcholinesterase inhibitor
0,160  0,047  Antifungal (Cryptococcus)
0,235  0,122  GST M1-1 substrate
0,175  0,062  Eye irritation, high
0,136  0,025  Carbonic anhydrase XIII inhibitor
0,218  0,107  Tyrosine 3 hydroxylase inhibitor
0,114  0,004  Transcription factor RelA inhibitor
0,123  0,016  Leukotriene synthesis inhibitor
0,136  0,030  Electron transport complex I inhibitor
0,133  0,027  Antiviral (SARS coronavirus)
0,133  0,027  Antiviral (Coronavirus)
0,153  0,048  DNA polymerase I inhibitor
0,159  0,055  Movement disorders treatment
0,173  0,069  Phospholipase C inhibitor
0,118  0,020  HIV-1 integrase (3'-Processing) inhibitor
0,163  0,066  Diuretic
0,138  0,042  Alcohol dehydrogenase substrate
0,213  0,118  Transcription factor STAT3 inhibitor
0,131  0,035  Urease inhibitor
0,136  0,042  Antiviral (Influenza B)
0,195  0,102  Antineoplastic (lymphocytic leukemia)
0,123  0,031  UGT2B11 substrate
0,112  0,022  Na+ K+ transporting ATPase inhibitor
0,151  0,068  Protein kinase stimulant
0,139  0,058  Antihelmintic (Trematoda)
0,102  0,022  HIV-1 integrase (Strand Transfer) inhibitor
0,120  0,040  Anabolic
0,124  0,044  Multidrug resistance-associated protein 1 inhibitor
0,207  0,128  Transcription factor STAT inhibitor
0,154  0,076  Carcinogenic, group 1
0,152  0,075  Interferon gamma antagonist
0,107  0,031  Macrophage migration inhibitory factor inhibitor
0,124  0,050  Mucolytic
0,106  0,032  Antibiotic
0,086  0,012  Estradiol 17 beta-dehydrogenase inhibitor
0,151  0,078  Hexokinase inhibitor
0,133  0,060  Vanilloid 1 agonist
0,114  0,042  Uric acid excretion stimulant
0,101  0,030  Keratolytic
0,120  0,050  HDL-cholesterol increasing
0,089  0,021  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,075  0,009  Retinoid X receptor agonist
0,117  0,051  Mediator release inhibitor
0,146  0,080  GABA C receptor rho-2 antagonist
0,102  0,036  Inducible nitric-oxide synthase inhibitor
0,163  0,098  Antirickettsial
0,075  0,012  Cathepsin L2 inhibitor
0,066  0,004  Estrogen-related receptor beta antagonist
0,090  0,029  Potassium channel large-conductance Ca-activated activator
0,114  0,053  UGT2B1 substrate
0,077  0,016  Leukotriene B4 antagonist
0,118  0,058  Aldehyde dehydrogenase substrate
0,078  0,018  Sphingosine kinase inhibitor
0,122  0,064  Proteasome inhibitor
0,084  0,028  Peroxisome proliferator-activated receptor gamma antagonist
0,151  0,095  Dual specificity phosphatase 3 inhibitor
0,083  0,028  Beta tubulin antagonist
0,079  0,024  Androgen agonist
0,138  0,083  Ca2+-transporting ATPase inhibitor
0,071  0,017  Dihydroorotate oxidase inhibitor
0,088  0,034  Phosphodiesterase V inhibitor
0,059  0,006  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,086  0,035  Phosphodiesterase 5A inhibitor
0,054  0,006  Leukotriene B4 receptor 1 antagonist
0,066  0,018  Glucose-6-phosphate translocase inhibitor
0,065  0,018  Potassium channel Kv1.3 blocker
0,128  0,082  Histone deacetylase SIRT1 inhibitor
0,065  0,020  Pregnane X receptor antagonist
0,069  0,024  Alpha tubulin antagonist
0,092  0,047  Antiviral (Trachoma)
0,218  0,174  Antiprotozoal (Plasmodium)
0,085  0,041  Telomerase inhibitor
0,056  0,013  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,176  0,135  Peptidyltransferase inhibitor
0,105  0,064  Glutathione S-transferase substrate
0,053  0,013  Retinoid X alpha receptor agonist
0,053  0,014  DNA gyrase subunit A inhibitor
0,044  0,005  Leukotriene B4 receptor 2 antagonist
0,057  0,021  Factor III inhibitor
0,114  0,080  Contraceptive female
0,048  0,014  Retinoid X receptor antagonist
0,056  0,022  Cholesterol esterase inhibitor
0,110  0,078  Beta amyloid protein antagonist
0,088  0,056  Androgen antagonist
0,058  0,027  Peroxisome proliferator-activated receptor alpha agonist
0,203  0,173  Antithrombotic
0,094  0,064  Bile acid receptor antagonist
0,143  0,114  Cyclin-dependent kinase 3 inhibitor
0,100  0,071  Antiinfertility, female
0,083  0,055  Thioredoxin reductase inhibitor
0,045  0,019  Retinoic acid alpha receptor agonist
0,117  0,092  Interleukin 1 antagonist
0,071  0,046  HIV-1 integrase inhibitor
0,113  0,088  Cyclooxygenase 2 inhibitor
0,198  0,175  Thioredoxin glutathione reductase inhibitor
0,083  0,061  Myeloperoxidase inhibitor
0,111  0,089  Toll-Like receptor 2 antagonist
0,050  0,028  Carbonic anhydrase VII inhibitor
0,038  0,017  Peroxisome proliferator-activated receptor delta antagonist
0,075  0,055  Narcotic antagonist
0,058  0,038  Postcoital contraceptive
0,089  0,069  Antiviral (Rhinovirus)
0,030  0,013  Sodium/glucose cotransporter 2 inhibitor
0,072  0,056  CYP2A6 inhibitor
0,063  0,047  Leukotriene antagonist
0,036  0,021  Retinoid X alpha receptor antagonist
0,067  0,051  Exportin-1 inhibitor
0,108  0,093  Cyclooxygenase 3 inhibitor
0,039  0,024  5-Alpha-reductase inhibitor
0,052  0,039  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,138  0,125  Cardiodepressant
0,048  0,036  Bombesin 2 receptor antagonist
0,059  0,048  Antimycoplasmal
0,079  0,070  D-Ala-D-Ala ligase inhibitor
0,087  0,079  Carbonic anhydrase III inhibitor
0,218  0,211  Transcription factor inhibitor
0,035  0,027  Inosine monophosphate dehydrogenase inhibitor
0,021  0,015  Neuraminidase (Influenza B) inhibitor
0,020  0,014  Inosine monophosphate dehydrogenase 1 inhibitor
0,024  0,021  Sodium/glucose cotransporter inhibitor
0,047  0,043  CD45 antagonist
0,088  0,086  Carbonic anhydrase XV inhibitor
0,181  0,179  Thyroid hormone antagonist
0,017  0,016  Inosine monophosphate dehydrogenase 2 inhibitor
0,082  0,082  Protein kinase C zeta inhibitor

